Journal of Ophthalmology / 2020 / Article / Fig 3

Research Article

Efficacy and Safety Outcomes of Intravitreal Dexamethasone Implant Therapy for the Treatment of Adult Coats’ Disease

Figure 3

Color fundus photograph of Case 1 in the DEX (+) group before and after the intravitreal injection of DEX implant, conbercept, and laser treatment. The patient was diagnosed with Coats’ disease classified as Stage 3A and consecutively observed for 16 months. 3A: color fundus photograph showing temporal periphery and macular telangiectasia, microaneurysms, large hard exudates, and ERD before intravitreal injection DEX implant, conbercept, and laser treatment; 3B: macular edema and lipid hard exudation were absorbed 4 months after the treatment, while the laser scar can be observed at temporal peripheral retina. 3C: retinal lipid hard exudation was absorbed absolutely at the macular area and temporal peripheral retina 1 year after the treatment.
(a)
(b)
(c)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.